Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the ...

Deep Brain Stimulation (DBS) involves implanting electrodes in specific areas of the brain that deliver electrical pulses to help regulate abnormal brain activity. This can alleviate symptoms such as ...

The two-step surgery implants permanent electrodes on one or both sides of the brain and a neurostimulator device (often ...

Distribution by Type of Device, Type of Neurostimulation Device, Application Area, Mode of Purchase, End-User and Geographical Region" report has been added to ResearchAndMarkets.com's offering.

Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Market (“Nasdaq”) on October 31, 2024, notifying the Company ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on November 5, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip ...